Checkout_my_Six
Touchdown! Greaser!
Ya but....no deaths....and antibodies. That has to be a positive....? or will you spin it as a negative?Phase I just means the vaccine hasn't killed anyone. It's actually a pretty low bar.
Ya but....no deaths....and antibodies. That has to be a positive....? or will you spin it as a negative?Phase I just means the vaccine hasn't killed anyone. It's actually a pretty low bar.
I'll believe it when it works. Which it hasn't. 30 years. I hope you will trust my expertise in these matters when I say that the vaccines still have significant technical hurdles.Ya but....no deaths....and antibodies. That has to be a positive....? or will you spin it as a negative?
Oh I do trust your expertise....and it's far easier to say it ain't possible than to have a glimmer of optimism.I'll believe it when it works. Which it hasn't. 30 years. I hope you will trust my expertise in these matters when I say that the vaccines still have significant technical hurdles.
Didn't say it was impossible, just a big uphill climb. In my biz promoters of new technology frequently overstate their results. I'm certain my biz is the only one where they do that...Oh I do trust your expertise....and it's far easier to say it ain't possible than to have a glimmer of optimism.
You guys want to explain that in basic English?
Phase I just means the vaccine hasn't killed anyone. It's actually a pretty low bar.
well....the new mRNA vaccines are producing antibodies......wonder if they'll produce T-cell immunity?
Similar to my reaction to a tetanus shot; I'd certainly stand in line to get this (unless it has a kill rate too similar to the virus itself.)The published results of Phase 1 trials say yes. Both the Moderna (mRNA) and Oxford (viral vector) vaccines elicit similar responses of both IgG antibodies and killer T cells after two doses 28 days apart. Good news for upcoming Phase 3 trials. Side effects are significant, similar to the Shingrix vaccine. Arm will hurt like hell, might feel a bit crappy for a day, but you will get a good immune response.